Guidelines for sclerotherapy of varicose veins;Leitlinien zur sklerosierungsbehandlung der vorikse

Phlebologie

Volumn 32, Issue 4, 2003, Pages 101-106

  Rabe, E ^a   Pannier Fischer, F ^a   Gerlach, H ^a   Breu, F X ^a   Guggenbichler, S ^a   Zabel, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

COLOR ULTRASOUND FLOWMETRY; HUMAN; PHLEBOGRAPHY; PHOTOELECTRIC PLETHYSMOGRAPHY; PRACTICE GUIDELINE; REVIEW; SCLEROTHERAPY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VARICOSIS;

EID: 0041825729     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621453     Document Type: Review

References (67)

1. Baccaglini U, Spreafico G, Castoro C, Sorrentino P. Consensus Conference on Sclerotherapy or Varicose Veins of the Lower Limbs. Phlebology 1997;12:2-16.
2. Baccaglini U, Stemmer R, Partsch U. Internationale Fragebogenaktion zur Praxis der Verödungsbehandlung. Phlebologie 1997;26:129-42.
3. Benigni JP, Sadoun S, Thirion V, Sica M, Demagny Y, Chahim M. Télangictasies et varices réticulaires Traitement par la mousse d'Aetoxisclérol á 0,25%. Présentation d'une étude pilote. Phlébologie 1999;52:283-90.
4. Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000;26:535-42.
5. Cavezzi A, Frullini A, Echosclerotherapy in the short saphenous vein insufficiency: personal experience. Abstract UIP, Sydney 1998.
6. Cavezzi A, Frullini A. Il ruola della mousse sclerosante nella ecosclerosi safenica e delle varici recidive. Esperienza personale. Flebologia 1998;9:1-3.
7. Conrad P, Malouf GM, Stacey MC: The Australian Polidocanol (Aethoxysklerol) Study. Results at 1 year. Phlebology 1994;9:17-20.
8. Conrad P, Malouf GM, Stacey MC The Australian Polidocanol (Aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995;21:334-6.
9. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 1996;34:523-8.
10. Dover J, N Sadick, MP Goldman. The role of lasers and light sources in the treatment of leg veins. Derm Surg 1999;25:328-36.
11. Einarsson E, Eklöf B, Neglén P. Sclerotherapy or Surgery as Treatment for Varicose Veins: A Prospective Randomized Study. Phlebology 1993;8:22-6.
12. Fegan WG. Continous compression technique of infecting varicose veins. Lancet 1963;109-12.
13. Feied CF. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Sem Dermatol 1993;12:135-49.
14. Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, Hashemiyoon RB. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994;20:466-8.
15. Feuerstein W. Schwere anaphylaktische Reaktion auf Hydroxypolyaethoxydodecan. VASA 1973;3:292-4.
16. Fisher DA. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000;26:1081.
17. Flückiger P. Nicht-operative retrograde Varizenverödung mit Varisylschaum. Schweiz Med Wochenschr 1956;48,1368-70.
18. Frullini A, Cavezzi A. Ultrasound guided sclerotherapy in the treatment of long saphenaous vein insufficiency. Vasomed 1999; 11 (Suppl 1): 8.
19. Frullini A. Sclerosing foam in the treatment of recurrent varicose veins. In: Henriet JP (ed). Foam sclerotherapy state of the art. Editions Phlebologiques Francaises 2001;73-8.
20. Georgiev M. Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 1993;19:649-52.
21. Geukens J, Rabe E, Bieber T. Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 1999;9:132-3.
22. Gobin J P. The sclerotherapy position in recurrent varicose veins treatment. Int Angiology 20; 2 (Suppl 1) 336:14.
23. Goldman PM. Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 1989;15:204-9.
24. Goldman PM, Beaudoing D, Marley W, Lopez L, Butie A. Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 1990:16:322-5.
25. Goldman PM, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 1995;21:19-29.
26. Goldmann PM. Complications of sclerotherapy. In: Gloviczki P, Yao J (eds). Handbook of venous disorders. London: Chapmann & Hall Medical 1996:374-93.
27. Grondin L, R Young, L Wouters. Sclérothérapie ècho-guidée et sécurité: Comparison des techniques. Phlebologie 1997;50:241-5.
28. Guex JJ. Ultrasound guided sclerotherapy (USGS) for perforating veins. Hawaii Med J 2000;59:261-2.
29. Härtel SL. Fünf-Jahres-Nachuntersuchungsergebnisse der Sklerosierungstherapie nach Stemmer bei 118 Patienten mit primärer Varikosis. Vasomed 1998;4:272-3.
30. Hamel-Desnos C, Desnos P, Ouvry P. Nouveautés thé rapeutiques dans la prise en charge de la maladie variqueuse: écho-sclérothérapie et mousse. Phlébologie 2003 56:41.
31. Henriet JP. One year experience with sclerotherapy of reticular veins and telangiectases using polidocanol foam in daily routine: feasibility results, complications. Phlébologie 1997;50:355-60.
32. Hohlbaum G. Uber iatrogene Schäden bei der Varizensklerosierung. In: Staubesand J, Schöpf E (Hrsg). Neuere Aspekte der Sklerosierungstherapie. Berlin, Heidelberg, New York: Springer 1990:70-81.
33. Hübner K. Ambulante Therapie der Stammvarikose mittels Krossektomie und Sklerotherapie - ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebologie 1991;20:104-8.
34. Kersting E, Hornschuh B, Bröcker E-B. Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 1998;27:55-7.
35. Kreussler. Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische Fabrik Kreussler & Co GmbH, Stand 2/1996.
36. Malouf GM. Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 2000;59:248-9.
37. Massay RA. Regarding the use of compression stockings after sclerotherapy. Dermatol Surg 1999;25:517.
38. Mayer H, Brücke H. Zur Ätiologie und Behandlung der Varizen der unteren Extremität. Chir Praxis 1957;4:521-8.
39. McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia - a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999;25:381-6.
40. McDonagh B. Comments on the use of post-sclerotherapy compression. Dermatol Surg 1999;25:519-21.
41. Monfreux A. Traitement sclérosant des troncs saphèniens et leurs collatèrales de gros calibre par la méthode mus. Phlébologie 1997;50:351-3.
42. Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia: Effects of increasing concentrations of polidocanol. J Am Acad of Dermatol 1989;20:643-9.
43. Oesch A, Stirnemann P, Mahler F. The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz Med Wochenschr 1984;114:1155-8.
44. Pradalier A, Vincent D, Hentschel V, Cohen-Jonathan AM, Daniel E. Allergie aux sclerosants des varices. Rev Fr Allergol 1995;35:440-3.
45. Rabe E (Hrsg). Grundlagen der Phlebologie. 2. Auflage. Köln: Viavital 2000.
46. Reddy P, Wickers J, Terry T, Lamont P, Moller J, Dormandy JA. What is the correct period of bandaging following sclerotherapy? Phlebology 1986;1:217-20.
47. Remy W, Vogt H-J, Borelli S. Embolia cutis medicamentosa-artige Hautnekrosen nach Sklerosierungsbehandlung. Phlebol Proktol 1978;7:67-72.
48. Sadoun S, Benigni JP. La mousse de sclerosant: etat de l'art. In: Rabe E et al. (Hrsg). Phlebology '99., Köln: Viavital 1999:146.
49. Seydewitz V, Staubesand J. Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schäden nach Sklerotherapie. In: Staubesand J, Schöpf E (Hrsg). Neuere Aspekte der Sklerosierungstherapie. Heidelberg: Springer 1990:40-65.
50. Sigg K. Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umschau 1949;6:127-34.
51. Schadeck M. Duplex-kontrollierte Sklerosierungsbehandlung der Vena saphena magna. Phlebologie 1996;25:78-82.
52. Schadeck M, Allaert FA. Résultats à long terme de la sclérothérapie des saphènes internes. Phlébologie 1997;50:257-62.
53. Schadeck M. Echo-sclerotherapy. Phlébologie 1999;52(special issue 10):103-6.
54. Schultz-Ehrenburg U, Tourbier H. Dopplerkontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol Proktol 1984;13:117-22.
55. Stanley PRW, Bickerton DR, Campbell WB. Injection sclerotherapy for varicose veins - a comparison of materials for applying local compression. Phlebology 1991;6:37-9.
56. Tazelaar DJ, Neumann HAM, de Roos KP. Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999;25:38-40.
57. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27,58-60.
58. Tessari L. Nouvelle technique d'obtention de la sclèro-mousse. Phlébologie 2000;53:129.
59. Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994;343:428.
60. Villavicencio J, Pfeifer J, Lohr J, Goldman M, Cranley R, Spence R. Sclerotherapy for varicose veins: Practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J (eds). Handbook of venous disorders. London: Chapmann & Hall Medical 1996:337-54.
61. Vin F. Principes de la sclérothéraphie des troncs saphènes internes. Phlébologie 1997;50:229-34.
62. Weiss RA, Weiss MA. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonics saline vs. polido-canol. J Dermatol Surg Oncol 1990;16:800-4.
63. Weiss RA, NS Sadick, MP Goldman, MA Weiss. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25:105-8.
64. Wenner L. Improvement of immediate and long-term results in sclerotherapy. VASA 1986;15:180-3.
65. Wollmann JC. Schaum - zwischen Vergangenheit und Zukunft. Vasomed 2002;16:34-8.
66. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000,26:323-8.
67. Yamaki T, Nozaki M, Fujiwara O, Yoshida E. Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 2002,28:619-22.